SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

AVXL RSS Feed
Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: blanka, TheHound, 123tom, kevindenver, TomP1, Rubyred77
Search This Board: 
Last Post: 4/23/2017 11:29:04 AM - Followers: 705 - Board type: Free - Posts Today: 41

Anavex Life Sciences Corp (AVXL)



Company website:  http://www.anavex.com/
 
 Nasdaq 
 
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA
1-844-689-3939

 
CIK:  0001314052
 
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s, CNS diseases and various types of cancer, which have significant unmet medical needs.
 
ANAVEX 2-73, the Company’s orally available drug candidate developed to treat Alzheimer’s through potential disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg.  Results from pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.
 
A highly encouraging synergistic effect has also been observed between ANAVEX 2-73 and donepezil (Aricept®).  The combined therapeutics, referred to as “ANAVEX PLUS,” produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually.
 
ANAVEX PLUS is believed to be a compelling commercial opportunity.  The clinical trial risk is lower because donepezil (Aricept®) is already on the market, with global sales of $4-billion annually.  Donepezil (Aricept®) is now generic and a patent application has been filed for ANAVEX PLUS which, if granted, would provide protection until 2033.
 
Management:   http://www.anavex.com/about-us/leadership/
 
Pipeline:  http://www.anavex.com/pipeline/

Patent Info: 
http://www.anavex.com/?s=patents

Clinical Trials:  https://clinicaltrials.gov/ct2/results?term=Anavex+Life+Sciences&Search=Search
 
Recent News:  http://finance.yahoo.com/q?s=avxl&ql=1
Company News Releases:  http://www.anavex.com/2015/?post_type=news
 
Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=anavex&owner=exclude&action=getcompany
 
Share Structure:  See SEC filings
 
Investor Relations:  ir@anavex.com

Marketing Details:  http://convention.bio.org/Printables/Anavex%20Life%20Sciences%20Corp..html

 



All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AVXL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
AVXL News: Current Report Filing (8-k) 04/21/2017 06:09:35 AM
AVXL News: Positive News in the Fight against Cancer Fuels Quest for More Good Tidings 04/18/2017 08:45:00 AM
AVXL News: Anavex Life Sciences Reports New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor 04/03/2017 07:00:00 AM
AVXL News: Anavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit 03/30/2017 08:00:00 AM
AVXL News: Anavex Life Sciences to Present at the 13th International Conference on Alzheimer's and Parkinson's Diseases AD/PD™ 2017 03/29/2017 08:00:00 AM
PostSubject
#101418  Sticky Note OK folks. While we realize that an occasional IH Admin [Edward] 04/18/17 06:45:04 AM
#99603  Sticky Note Basic biology concepts for Alzheimer’s disease (updated 4/1/2017) XenaLives 04/05/17 10:39:21 AM
#94047  Sticky Note Found a nice A-273 profile overview. Rubyred77 03/02/17 02:06:17 PM
#102640   it is only if it fits the narrative. kld2 04/23/17 11:52:43 AM
#102639   Seems like so many are looking for a blueyedcatch 04/23/17 11:29:04 AM
#102638   Just skimmed a smattering of 10Ks that refer XenaLives 04/23/17 11:09:58 AM
#102637   Hopefully soon - until then at least we raja48185 04/23/17 11:06:02 AM
#102636   I didn't make an argument - I stated fact.\ XenaLives 04/23/17 11:05:19 AM
#102635   IMO, Ariana must long be done with any Djia 04/23/17 10:49:15 AM
#102634   Did the pulled abstract have new data, numbers? kld2 04/23/17 10:39:21 AM
#102633   I agree that we need to play the Ziggydmz1 04/23/17 10:36:09 AM
#102632   So if My statement is false - give Amatuer17 04/23/17 10:25:27 AM
#102631   False... So as long as it is not declared XenaLives 04/23/17 10:11:57 AM
#102629   Okay, then, Missling can hold it as he kld2 04/23/17 10:03:07 AM
#102628   It is highly material. Top of the scottsmith 04/23/17 10:02:37 AM
#102627   Good try to save on words. Yes - the Amatuer17 04/23/17 09:59:36 AM
#102626   The ATM assures that new stock will be XenaLives 04/23/17 08:30:48 AM
#102625   The LPC "accommodation" from three day averaging is LakeshoreLeo1953 04/23/17 08:26:36 AM
#102624   But public release of PK/PD is immaterial. XenaLives 04/23/17 08:26:27 AM
#102623   Got to get some positive news soon !!!!!!!!! plexrec 04/23/17 08:24:59 AM
#102622   No way... Trazodone has way too many side XenaLives 04/23/17 08:24:59 AM
#102621   Is institutional ownership good bad or indifferent? This k9uwa 04/23/17 07:55:59 AM
#102619   Don't equate what is said with what is kld2 04/23/17 07:11:28 AM
#102618   Time and again said here that P2/3 and Amatuer17 04/23/17 07:01:49 AM
#102617   AVXL competitor?...hhhmmm. nicholast 04/23/17 06:59:20 AM
#102616   Since release of PK/PD is not material to XenaLives 04/23/17 06:31:42 AM
#102615   My point was to address the folks who Biostockclub 04/23/17 06:27:07 AM
#102614   My point has been the delay in pk/pd Amatuer17 04/23/17 06:24:36 AM
#102613   I am of the opinion that I trust XenaLives 04/23/17 06:24:16 AM
#102612   Tom, Thanks for the kind words and thoughts about Biostockclub 04/23/17 06:23:07 AM
#102611   You said: "So the above incorrectly states that a F1ash 04/23/17 06:19:40 AM
#102610   Company never said Ariana would be used for Biostockclub 04/23/17 06:10:48 AM
#102609   Yes, absolutely. In all likelihood that's what our Biostockclub 04/23/17 05:56:03 AM
#102608   " The lack of information on the three Amatuer17 04/23/17 05:55:00 AM
#102607   Could it be preventive ? eagle8 04/23/17 03:42:47 AM
#102606   like a zen meditation while riding on 123tom 04/23/17 03:17:16 AM
#102604   AVXL chart.... 123tom 04/23/17 01:51:29 AM
#102603   More about the slowdown at the FDA. Talon38 04/23/17 01:33:54 AM
#102602   Great post,Biostockclub... 123tom 04/23/17 01:30:54 AM
#102601   Bas. With preferred shares a non-factor now, IMHO Talon38 04/23/17 01:05:37 AM
#102600   My objection was to this original statement, thanks XenaLives 04/23/17 12:53:06 AM
#102599   Poison Pill in place... basparks79 04/22/17 10:48:10 PM
#102598   Good stuff. It looks like I better buy Batermere 04/22/17 10:44:53 PM
#102597   Agree it can be amazing but so what? It Amatuer17 04/22/17 10:23:55 PM
#102596   Now that most of the poison pill is basparks79 04/22/17 10:23:32 PM
#102595   729k shares might not qualify for filing. Or basparks79 04/22/17 10:12:28 PM
#102594   ATM = At the market financing. PIPES are kevindenver 04/22/17 10:03:55 PM
#102590   If so. Missling should just tell us. It Jonjones325 04/22/17 09:38:26 PM
#102589   My stop loss is set to $225...everyone please Ziggydmz1 04/22/17 09:37:14 PM
#102588   Ya they probably could have knocked it out Williamsc 04/22/17 09:36:11 PM
#102586   I think the clinical folks would take over Biostockclub 04/22/17 09:33:48 PM
#102585   IMO. A BP can't wait for more data. Jonjones325 04/22/17 09:32:55 PM
#102584   I thought that at first too, I must Biostockclub 04/22/17 09:29:16 PM
PostSubject